Sign In

Translating for FDA, EMA, PMDA, and NMPA: Best Practices for Global Regulatory Submissions

Translating for FDA, EMA, PMDA, and NMPA: Best Practices for Global Regulatory Submissions Globalization has transformed the life sciences industry, with pharmaceutical, biotechnology, and medical device companies increasingly seeking simultaneous regulatory approvals across multiple regions. To support these global submissions, accurate and compliant translation of regulatory documents has become a critical component of the approval […]

Read More

Ai Mtpe Life Sciences Translation

AI and MTPE in Life Sciences Translation: What Works, What Doesn’t Advancements in artificial intelligence (AI) are transforming how life sciences organizations approach multilingual content. One of the most widely adopted applications is Machine Translation Post-Editing (MTPE), a process where AI-generated translations are reviewed and refined by professional linguists to achieve publication-quality results. In parallel, […]

Read More

Challenges In Regulatory Translation Global Submissions

Key Challenges in Regulatory Translation for Global Submissions Accurate and compliant translation is essential for successful regulatory submissions in the life sciences sector. As pharmaceutical, biotech, and medical device companies expand into international markets, they must prepare multilingual dossiers that meet the specific requirements of global regulatory bodies. Each authority—whether the EMA, FDA, PMDA, or […]

Read More

Top Trends in Medical Translation for 2025

Top Trends in Medical Translation for 2025 What’s shaping the future of life sciences localization? From regulatory harmonization to AI-driven content reuse, discover the trends redefining translation workflows across the healthcare and biopharma sectors. Meeting Global Medical Translation Demands in 2025 As the global life sciences industry faces mounting regulatory complexity, accelerated product cycles, and […]

Read More